US FDA’s Absence Raises Concerns In International Standards Development

The FDA's recent communication freeze has blocked participation in international standards development groups. The agency's absence could impact the alignment of US and international standards, potentially affecting medical device manufacturers' ability to sell products globally.

Handshake in front of globe representing international cooperation
(metamorworks/Shutterstock)

More from Medtech Insight

More from Compliance